MSD’s monoclonal antibody, indicated for 15 types of cancer, smashed industry records with sales of $27.3 billion in 2024, ...

Recent market volatility notwithstanding, equities generally deliver solid returns over long periods, like a decade. The key ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Oracle Corp.

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...

With the FDA appearing to be undergoing major disruption under new leadership, BofA analyst Tim Anderson says one way to assess the risk from ...

According to the private global space research and consulting firm Novaspace, a total of 1,842 satellites were launched into ...

While there continues to be a trickle of acquisitions — including AstraZeneca’s recent $1bn bid for EsoBiotec — big pharma has largely focused on licensing deals, often with Chinese biotechs. These ...

NIH trial shows new form of TIL therapy effective against colon, rectum, pancreas, and bile duct tumors.

CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two patients. Optimal Treatment Response: Three patients achieved partial response (PR), while ten patients had stable ...